Paula Saz-Leal

6PUBLICATIONS
17CO-AUTHORS
Medical infection agents (incl. prions)Pacific Peoples theory of change models for healthClinical pharmacy and pharmacy practiceAllergyPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 25, 2024
MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. coli in Experimental Urinary Tract Infection.

Paula Saz-Leal, Marianne Morris Ligon, Carmen María Diez-Rivero

|Sep 11, 2023
Combination of Soy Isoflavones, 8-Prenylnaringenin and Melatonin Improves Hot Flashes and Health-Related Quality of Life Outcomes in Postmenopausal Women: Flavie Study.

Carmela Puchol Estrugo, Miriam Trujillo Rodríguez, Nicolás Mendoza-Ladrón de Guevara

|Jun 19, 2023
MV140 mucosal bacterial vaccine improves uropathogenic E. coli clearance in an experimental model of urinary tract infection.

Paula Saz-Leal, Marianne M Ligon, Carmen M Diez-Rivero

|Jun 15, 2023
Bioavailability of Cariban® Capsules: A Modified-Release Fixed-Dose Combination of Doxylamine and Pyridoxine to Relieve Nausea and Vomiting During Pregnancy.

Paula Saz-Leal, Laura Zamorano-Domínguez, Jesús Frías

|Mar 11, 2021
Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.

Antonio Nieto, Angel Mazón, María Nieto

|Oct 20, 2018
DNGR-1 in dendritic cells limits tissue damage by dampening neutrophil recruitment.

Carlos Del Fresno, Paula Saz-Leal, Michel Enamorado

Pageof 1

Frequent Collaborators

2 joint publications

David Sancho

2 joint publications

Laura Conejero

2 joint publications

José Luis Subiza

1 joint publications

Carlos Del Fresno